In addition to the potential impact on disease course, a secondary issue that must be considered in IBD management is the influence of GLP-1 RAs on bowel preparation for colonoscopy and video capsule endoscopy (VCE) given the slower gastric and intestinal transit observed in patients on GLP-1-based therapy [81]. This evidence concerns the gene GLP1R and inflammatory bowel disease.